Benchmark Research - San Angelo - HyperCore - PPDS

San Angelo, Texas 76904-7610

0 studies enrolling now · 3 studies all time

What they study most

Cytomegalovirus, Influenza, Respiratory Syncytial Virus, SARS-CoV-2

Studies at this site

• A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age — Completed
• A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults — Running, not enrolling
• A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age — Completed